Hyundai Pharmaceutical Co Ltd
KRX:004310
Dividends
Dividend Yield
Hyundai Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hyundai Pharmaceutical Co Ltd
Hyundai Pharmaceutical Co Ltd have
increased
by 44%.
Payout Ratio
Hyundai Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Hyundai Pharmaceutical Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Hyundai Pharmaceutical Co Ltd
| Average Annual Return | -17.73% |
| Standard Deviation of Annual Returns | 6.8% |
| Max Drawdown | -65% |
| Market Capitalization | 311.5B KRW |
| Shares Outstanding | 26 135 698 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Hyundai Pharmaceutical Co Ltd's latest stock split occurred on Oct 20, 2017
The company executed a 1816-for-1769 stock split, meaning that for every 1769 shares held, investors received 1816 new shares.
Before the split, Hyundai Pharmaceutical Co Ltd traded at 3669.9989 per share. Afterward, the share price was about 3387.0947.
The adjusted shares began trading on Oct 20, 2017. This was Hyundai Pharmaceutical Co Ltd's 11th stock split, following the previous one in Mar 17, 2008.
